Literature DB >> 6572938

Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination.

T D Shultz, J Fox, H Heath, R Kumar.   

Abstract

Recent experiments have shown that 1,25-dihydroxyvitamin D3-like material is produced in cultured nonrenal cells and may be present in the sera of anephric patients. We reexamined the question of whether 1,25-dihydroxyvitamin D3 can be synthesized extrarenally in the rat in vivo. To intact, sham-operated, ureter-ligated, or acutely nephrectomized vitamin D-deficient rats raised on a diet normal in calcium and phosphorus, we gave a physiologic dose of high-specific-activity 25-hydroxy-[3H]vitamin D3 (3.6-3.8 microCi; approximately equal to 25 pmol per rat). Twenty-four hours later we examined their tissues and plasma for the presence of radiolabeled 1,25-dihydroxyvitamin D3. Large amounts of radioactivity that behaved chromatographically as identical with authentic 1,25-dihydroxyvitamin D3 were present in the plasma, bone, and intestine of the intact, sham-operated, or ureter-ligated rats. However, no radioactivity eluting in a manner similar to 1,25-dihydroxyvitamin D3 was found in plasma, bone, or intestine of acutely nephrectomized rats. We conclude that, in the acutely nephrectomized living rat, 1,25-dihydroxyvitamin D3 is not present in plasma, bone, or intestine in quantities detectable by the sensitive techniques we have used. No conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 was observed during a 24-hr period after nephrectomy of vitamin D-deprived rats. This fact casts doubt upon the significance of the in vitro production of 1,25-dihydroxyvitamin D3 by nonrenal cells as an in vivo phenomenon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6572938      PMCID: PMC393681          DOI: 10.1073/pnas.80.6.1746

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography.

Authors:  J A Eisman; R M Shepard; H F DeLuca
Journal:  Anal Biochem       Date:  1977-05-15       Impact factor: 3.365

2.  The metabolism of vitamin D3 and 25-hydroxyvitamin D3 in normal and anephric humans.

Authors:  R W Gray; H P Weber; J H Dominguez; J Lemann
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

3.  Evidence for formation of 1,25-dihydroxycholecalciferol during metabolism of vitamin D in man.

Authors:  E B Mawer; J Backhouse; G A Lumb; S W Stanbury
Journal:  Nat New Biol       Date:  1971-08-11

4.  Vitamin D metabolism: the role of kidney tissue.

Authors:  R Gray; I Boyle; H F DeLuca
Journal:  Science       Date:  1971-06-18       Impact factor: 47.728

5.  Biological activity of 25-hydroxyergocalciferol in rats.

Authors:  T Suda; H F DeLuca; Y Tanaka
Journal:  J Nutr       Date:  1970-09       Impact factor: 4.798

6.  Unique biosynthesis by kidney of a biological active vitamin D metabolite.

Authors:  D R Fraser; E Kodicek
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

7.  1,25-Dihydroxyvitamin D in biological fluids: a simplified and sensitive assay.

Authors:  J A Eisman; A J Hamstra; B E Kream; H F DeLuca
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

8.  Synthesis of 1,25-dihydroxyvitamin D in the nephrectomized pregnant rat.

Authors:  Y Weisman; A Vargas; G Duckett; E Reiter; A W Root
Journal:  Endocrinology       Date:  1978-12       Impact factor: 4.736

9.  Radioreceptor assay for 1 alpha,25-dihydroxyvitamin D3.

Authors:  P F Brumbaugh; D H Haussler; R Bressler; M R Haussler
Journal:  Science       Date:  1974-03-15       Impact factor: 47.728

10.  Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation.

Authors:  R Kumar; W R Cohen; P Silva; F H Epstein
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

View more
  11 in total

1.  CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin.

Authors:  Janeen L Vanhooke; Jean M Prahl; Christine Kimmel-Jehan; Monica Mendelsohn; Eric W Danielson; Kevin D Healy; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

Review 2.  Vitamin D and the kidney.

Authors:  Rajiv Kumar; Peter J Tebben; James R Thompson
Journal:  Arch Biochem Biophys       Date:  2012-03-15       Impact factor: 4.013

3.  1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation.

Authors:  D D Bikle; M K Nemanic; E Gee; P Elias
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 4.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

5.  Murine CD8+ T cells but not macrophages express the vitamin D 1α-hydroxylase.

Authors:  Jot Hui Ooi; Kaitlin L McDaniel; Veronika Weaver; Margherita T Cantorna
Journal:  J Nutr Biochem       Date:  2013-10-10       Impact factor: 6.048

6.  25-Hydroxyvitamin D3-1 alpha-hydroxylase in porcine hepatic tissue: subcellular localization to both mitochondria and microsomes.

Authors:  B W Hollis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 7.  Vitamin D and host resistance to infection? Putting the cart in front of the horse.

Authors:  Danny Bruce; Jot Hui Ooi; Sanhong Yu; Margherita T Cantorna
Journal:  Exp Biol Med (Maywood)       Date:  2010-08

8.  Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.

Authors:  Jason R Stubbs; Arun Idiculla; Joyce Slusser; Rochelle Menard; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2009-12-10       Impact factor: 10.121

Review 9.  Vitamin D and multiple sclerosis.

Authors:  Anita Raghuwanshi; Sneha S Joshi; Sylvia Christakos
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

Review 10.  The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.

Authors:  Ladan Zand; Rajiv Kumar
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.